Novel hyperactive glucocorticoid receptor isoform identified within a human population

Kelly Tung, Aaron C. Baker, Amir Amini, Tajia L. Green, Victoria W. Chew, Debora Lim, Sally T. Nguyen, Kristen S. Yee, Kiho Cho, David G Greenhalgh

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Glucocorticoids serve as important therapeutic agents in diseases of inflammation, but clinical use, especially in advanced septic shock, remains controversial because of the unpredictable response. Prior studies correlate human glucocorticoid receptor (hGR) isoforms with a decreased response to steroid therapy. Further analysis of additional hGR isoforms may improve the understanding of the steroid response. Ninety-seven human volunteers' blood samples were surveyed for hGR isoforms. An isoform matching National Center for Biotechnology Informatics (NCBI) hGRα (hGR NCBI) served as a reference. Two isoforms were of particular interest-one isoform had three nonsynonymous single-nucleotide polymorphisms (SNPs) (hGR NS-1), and the second had a single-nucleotide deletion (hGR DL-1) resulting in a truncated protein. Transactivation potentials were measured using a luciferase reporter assay. Human glucocorticoid receptor NS-1 had activity more than twice of hGR NCBI, whereas hGR DL-1 demonstrated less than 10% of the activity of hGR NCBI. Cotransfection of two isoforms revealed that the presence of hGR NS-1 increased transactivation potential, whereas hGR DL-1 decreased activity. Synthetic constructs isolating individual and paired SNPs of hGR NS-1 were created to identify the SNP responsible for hyperactivity. Transactivation studies revealed a SNP within the ligand-binding domain exerted the greatest influence over hyperactivity. In evaluating the response to hydrocortisone, hGR NCBI and hGR NS-1 displayed an increased dose-dependent response, but hGR NS-1 had a response more than twice hGR NCBI. Characterization of the novel hyperactive hGR NS-1 provides insight into a possible mechanism underlying the unpredictable response to steroid treatment.

Original languageEnglish (US)
Pages (from-to)339-344
Number of pages6
JournalShock
Volume36
Issue number4
DOIs
StatePublished - Oct 2011

Fingerprint

Glucocorticoid Receptors
Protein Isoforms
Population
Informatics
Biotechnology
Single Nucleotide Polymorphism
Transcriptional Activation
Steroids

Keywords

  • adrenal insufficiency
  • Human glucocorticoid receptor
  • inflammation
  • sepsis
  • steroids
  • stress response

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Emergency Medicine

Cite this

Novel hyperactive glucocorticoid receptor isoform identified within a human population. / Tung, Kelly; Baker, Aaron C.; Amini, Amir; Green, Tajia L.; Chew, Victoria W.; Lim, Debora; Nguyen, Sally T.; Yee, Kristen S.; Cho, Kiho; Greenhalgh, David G.

In: Shock, Vol. 36, No. 4, 10.2011, p. 339-344.

Research output: Contribution to journalArticle

Tung, K, Baker, AC, Amini, A, Green, TL, Chew, VW, Lim, D, Nguyen, ST, Yee, KS, Cho, K & Greenhalgh, DG 2011, 'Novel hyperactive glucocorticoid receptor isoform identified within a human population', Shock, vol. 36, no. 4, pp. 339-344. https://doi.org/10.1097/SHK.0b013e318228eca7
Tung, Kelly ; Baker, Aaron C. ; Amini, Amir ; Green, Tajia L. ; Chew, Victoria W. ; Lim, Debora ; Nguyen, Sally T. ; Yee, Kristen S. ; Cho, Kiho ; Greenhalgh, David G. / Novel hyperactive glucocorticoid receptor isoform identified within a human population. In: Shock. 2011 ; Vol. 36, No. 4. pp. 339-344.
@article{af459dad51954d6da5f6c90c35bd7c49,
title = "Novel hyperactive glucocorticoid receptor isoform identified within a human population",
abstract = "Glucocorticoids serve as important therapeutic agents in diseases of inflammation, but clinical use, especially in advanced septic shock, remains controversial because of the unpredictable response. Prior studies correlate human glucocorticoid receptor (hGR) isoforms with a decreased response to steroid therapy. Further analysis of additional hGR isoforms may improve the understanding of the steroid response. Ninety-seven human volunteers' blood samples were surveyed for hGR isoforms. An isoform matching National Center for Biotechnology Informatics (NCBI) hGRα (hGR NCBI) served as a reference. Two isoforms were of particular interest-one isoform had three nonsynonymous single-nucleotide polymorphisms (SNPs) (hGR NS-1), and the second had a single-nucleotide deletion (hGR DL-1) resulting in a truncated protein. Transactivation potentials were measured using a luciferase reporter assay. Human glucocorticoid receptor NS-1 had activity more than twice of hGR NCBI, whereas hGR DL-1 demonstrated less than 10{\%} of the activity of hGR NCBI. Cotransfection of two isoforms revealed that the presence of hGR NS-1 increased transactivation potential, whereas hGR DL-1 decreased activity. Synthetic constructs isolating individual and paired SNPs of hGR NS-1 were created to identify the SNP responsible for hyperactivity. Transactivation studies revealed a SNP within the ligand-binding domain exerted the greatest influence over hyperactivity. In evaluating the response to hydrocortisone, hGR NCBI and hGR NS-1 displayed an increased dose-dependent response, but hGR NS-1 had a response more than twice hGR NCBI. Characterization of the novel hyperactive hGR NS-1 provides insight into a possible mechanism underlying the unpredictable response to steroid treatment.",
keywords = "adrenal insufficiency, Human glucocorticoid receptor, inflammation, sepsis, steroids, stress response",
author = "Kelly Tung and Baker, {Aaron C.} and Amir Amini and Green, {Tajia L.} and Chew, {Victoria W.} and Debora Lim and Nguyen, {Sally T.} and Yee, {Kristen S.} and Kiho Cho and Greenhalgh, {David G}",
year = "2011",
month = "10",
doi = "10.1097/SHK.0b013e318228eca7",
language = "English (US)",
volume = "36",
pages = "339--344",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Novel hyperactive glucocorticoid receptor isoform identified within a human population

AU - Tung, Kelly

AU - Baker, Aaron C.

AU - Amini, Amir

AU - Green, Tajia L.

AU - Chew, Victoria W.

AU - Lim, Debora

AU - Nguyen, Sally T.

AU - Yee, Kristen S.

AU - Cho, Kiho

AU - Greenhalgh, David G

PY - 2011/10

Y1 - 2011/10

N2 - Glucocorticoids serve as important therapeutic agents in diseases of inflammation, but clinical use, especially in advanced septic shock, remains controversial because of the unpredictable response. Prior studies correlate human glucocorticoid receptor (hGR) isoforms with a decreased response to steroid therapy. Further analysis of additional hGR isoforms may improve the understanding of the steroid response. Ninety-seven human volunteers' blood samples were surveyed for hGR isoforms. An isoform matching National Center for Biotechnology Informatics (NCBI) hGRα (hGR NCBI) served as a reference. Two isoforms were of particular interest-one isoform had three nonsynonymous single-nucleotide polymorphisms (SNPs) (hGR NS-1), and the second had a single-nucleotide deletion (hGR DL-1) resulting in a truncated protein. Transactivation potentials were measured using a luciferase reporter assay. Human glucocorticoid receptor NS-1 had activity more than twice of hGR NCBI, whereas hGR DL-1 demonstrated less than 10% of the activity of hGR NCBI. Cotransfection of two isoforms revealed that the presence of hGR NS-1 increased transactivation potential, whereas hGR DL-1 decreased activity. Synthetic constructs isolating individual and paired SNPs of hGR NS-1 were created to identify the SNP responsible for hyperactivity. Transactivation studies revealed a SNP within the ligand-binding domain exerted the greatest influence over hyperactivity. In evaluating the response to hydrocortisone, hGR NCBI and hGR NS-1 displayed an increased dose-dependent response, but hGR NS-1 had a response more than twice hGR NCBI. Characterization of the novel hyperactive hGR NS-1 provides insight into a possible mechanism underlying the unpredictable response to steroid treatment.

AB - Glucocorticoids serve as important therapeutic agents in diseases of inflammation, but clinical use, especially in advanced septic shock, remains controversial because of the unpredictable response. Prior studies correlate human glucocorticoid receptor (hGR) isoforms with a decreased response to steroid therapy. Further analysis of additional hGR isoforms may improve the understanding of the steroid response. Ninety-seven human volunteers' blood samples were surveyed for hGR isoforms. An isoform matching National Center for Biotechnology Informatics (NCBI) hGRα (hGR NCBI) served as a reference. Two isoforms were of particular interest-one isoform had three nonsynonymous single-nucleotide polymorphisms (SNPs) (hGR NS-1), and the second had a single-nucleotide deletion (hGR DL-1) resulting in a truncated protein. Transactivation potentials were measured using a luciferase reporter assay. Human glucocorticoid receptor NS-1 had activity more than twice of hGR NCBI, whereas hGR DL-1 demonstrated less than 10% of the activity of hGR NCBI. Cotransfection of two isoforms revealed that the presence of hGR NS-1 increased transactivation potential, whereas hGR DL-1 decreased activity. Synthetic constructs isolating individual and paired SNPs of hGR NS-1 were created to identify the SNP responsible for hyperactivity. Transactivation studies revealed a SNP within the ligand-binding domain exerted the greatest influence over hyperactivity. In evaluating the response to hydrocortisone, hGR NCBI and hGR NS-1 displayed an increased dose-dependent response, but hGR NS-1 had a response more than twice hGR NCBI. Characterization of the novel hyperactive hGR NS-1 provides insight into a possible mechanism underlying the unpredictable response to steroid treatment.

KW - adrenal insufficiency

KW - Human glucocorticoid receptor

KW - inflammation

KW - sepsis

KW - steroids

KW - stress response

UR - http://www.scopus.com/inward/record.url?scp=80052965328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052965328&partnerID=8YFLogxK

U2 - 10.1097/SHK.0b013e318228eca7

DO - 10.1097/SHK.0b013e318228eca7

M3 - Article

VL - 36

SP - 339

EP - 344

JO - Shock

JF - Shock

SN - 1073-2322

IS - 4

ER -